Skip to main content
TipRanks
Go Ultimate75% OFF

Compare TG Therapeutics (NKB2) vs. Competitors

3 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:NKB2TG TherapeuticsEUR 61.20EUR 8.94B87.10130.16%Moderate BuyUnlock the DE:NKB2 analyst price target with TipRanks PremiumDE:NKB2Unlock the DE:NKB2 top-analyst price target with TipRanks Premium
PTGXProtagonist Therapeutics$124.02$8.09B24.0445.68%Strong BuyUnlock the PTGX analyst price target with TipRanks PremiumDE:NKB2 vs PTGXUnlock the PTGX top-analyst price target with TipRanks Premium
IMVTImmunovant$32.52$6.73B-12.7040.41%Moderate BuyUnlock the IMVT analyst price target with TipRanks PremiumDE:NKB2 vs IMVTUnlock the IMVT top-analyst price target with TipRanks Premium
ARQTArcutis Biotherapeutics$27.17$3.44B116.76-2.58%Strong BuyUnlock the ARQT analyst price target with TipRanks PremiumDE:NKB2 vs ARQTUnlock the ARQT top-analyst price target with TipRanks Premium
LEGNLegend Biotech$16.10$3.12B-1610.00-42.50%Moderate BuyUnlock the LEGN analyst price target with TipRanks PremiumDE:NKB2 vs LEGNUnlock the LEGN top-analyst price target with TipRanks Premium
KYMRKymera Therapeutics$119.39$10.19B-32.8984.19%Strong BuyUnlock the KYMR analyst price target with TipRanks PremiumDE:NKB2 vs KYMRUnlock the KYMR top-analyst price target with TipRanks Premium

Performance Comparison

-50%0%50%100%150%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:NKB2TG Therapeutics61.2034.36127.98%
PTGXProtagonist Therapeutics124.0239.8247.29%
IMVTImmunovant32.529.7342.69%
ARQTArcutis Biotherapeutics27.17-0.16-0.59%
LEGNLegend Biotech16.10-11.43-41.52%
KYMRKymera Therapeutics119.3954.7684.73%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts